Literature DB >> 8682100

Cytomegalovirus-associated heart muscle disease.

U Schönian1, M Crombach, S Maser, B Maisch.   

Abstract

Human cytomegalovirus (CMV) can persist in many organs after primary infection. Not only is it suspected to cause morbidity during reactivation in patients under immunosuppression, but it may also induce long-term latency by chronic disease, e.g. in the myocardium. Endomyocardial biopsies of 27 patients with active myocarditis, 35 patients with healing, 41 patients with healed and 25 patients with ongoing myocarditis according to the Dallas Criteria and 52 patients with dilated cardiomyopathy (DCM) and the biopsies of 25 healthy heart donors were studied for persisting CMV-DNA by polymerase chain reaction (PCR) and in-situ hybridization (ISH). CMV-DNA could be assessed in 5-14% of patients in the different stages of myocarditis and in 22% of patients with DCM. Although two biopsies of the control group showed a positive result, studies by in-situ hybridization demonstrated that in patients with heart muscle disease CMV persists in all cell types including myocytes, whereas in the controls it is only found in interstitial cells. CMV antigens could not be detected in the myocardium with our methods. It must be assumed that infection by CMV is more a persistent or latent than an active infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8682100     DOI: 10.1093/eurheartj/16.suppl_o.46

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Cytomegalovirus hepatitis and myopericarditis.

Authors:  Leire Zubiaurre; Eva Zapata; Luis Bujanda; María Castillo; Igor Oyarzabal; Maria A Gutiérrez-Stampa; Angel Cosme
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 2.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 3.  Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies.

Authors:  Matthias Pauschinger; Kumaran Chandrasekharan; Michel Noutsias; Uwe Kühl; Lothar Peter Schwimmbeck; Heinz-Peter Schultheiss
Journal:  Med Microbiol Immunol       Date:  2004-01-14       Impact factor: 3.402

Review 4.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Molecular pathology of inflammatory cardiomyopathy.

Authors:  Karin Klingel; Martina Sauter; C Thomas Bock; Gudrun Szalay; Jens-Jörg Schnorr; Reinhard Kandolf
Journal:  Med Microbiol Immunol       Date:  2003-08-14       Impact factor: 3.402

6.  Molecular Aspects of Myocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.663

Review 7.  Amplification of autoimmune disease by infection.

Authors:  David N Posnett; Dmitry Yarilin
Journal:  Arthritis Res Ther       Date:  2005-02-10       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.